Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis

Journal of Dermatological Treatment

Volumn 10, Issue 3, 1999, Pages 189-193

  Memişoǧlu, Hamdi R ^a   Erboz, S ^b   Akkaya, S ^c   Akan, T ^c   Aksungur, V L ^a   Unal I ^c   Karakas M ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Griseofulvin; Terbinafine; Tinea capitis

Indexed keywords

ANTIFUNGAL AGENT; ASPARTATE AMINOTRANSFERASE; GRISEOFULVIN; TERBINAFINE;

ADOLESCENT; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HEMATOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TINEA CAPITIS;

EID: 0345466374     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056027     Document Type: Article

References (16)

1. Abdel-Rahman SM, Nahata MC, Oral terbinafine: a new antifungal agent. Ann Pharmacother (1997) 31: 445-56.
2. Jones TC, Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol (1995) 132: 683-9.
3. Degreef HJ, DeDoncker PRG, Current therapy of dermatophytosis. J Am Acad Dermatol (1994) 31 (Suppl): 25-30.
4. Finlay AY, Global overview of lamisil. Br J Dermatol (1994) 130 (Suppl 43): 1-3.
5. Gnamusch E, Ryder NS, Paltauf F, Effect of squalene on the structure and function of fungal membranes. J Dermatol Treat (1992) 3 (Suppl 1): 9-13.
6. Ryder NS, Terbinafine: mode of action and properties of the squalene oxidase inhibitor. Br J Dermatol (1992) 126 (Suppl 39): 2-7.
7. Ryder NS, Selective action of allylamines and its therapeutic implications. J Dermatol Treat (1992) 3 (Suppl 1): 3-7.
8. Clayton YM, Relevance of broad spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol (1994) 130 (Suppl 43): 7-8.
9. Kullavanijaya P, Reangchainam S, Ungpakorn R, Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. Abstracts book, Clinical Dermatology 2000, an International Congress, Vancouver, Canada, 28-31 May 1996, Abstract GPI, 160.
10. Haroon TS, Hussain I, Amon S, A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol (1996) 135: 86-8.
11. Nejjam F, Zagula M, Cabiac MD, Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol (1995) 132: 98-105.
12. Haroon TS, Hussain I, Amon S, A randomized, double-blind comparative study of terbinafine vs. tinea capitis. Br J Dermatol (1995) 6: 167-9.
13. Talarico SF et al, Efficacy and tolerability of terbinafine tablets in the treatment of children with tinea capitis. Abstracts book, Fourth Annual International Summit on Cutaneous Antifungal Therapy, Vancouver, Canada, 26-28 May 1996, Abstract 73.
14. Köleman F, Dermatopyhtic flora of Ankara (Turkey). Dermatologica (1981) 162: 260-4.
15. Aksungur L, Doǧu Anadolunun dermatophytic florasi. In: Tat AC, Gürhan N, Kematili H, Or N, (eds) II. Ulusal Dermatoloji Kongresi. Ongun Karjesler Motbuosi: Ankara, Turkey 1968, Kongre Kitabi 209-212.
16. Bruckbauer HR, Hofmann H, Systemic antifungal treatment of children with terbinafine. Dermatology (1997) 195: 134-6.